Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Ardizzone

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 23, 2021
Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's diseaseGianluca M Sampietro, Giovanni Maconi, Francesco Colombo, et al.
Haematologica|October 10, 2009
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatmentGaetano Bergamaschi, Antonio Di Sabatino, Riccardo Albertini, et al.
Journal of Crohn'S & Colitis|September 24, 2011
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel diseaseLaurent Peyrin-Biroulet, Marc Ferrante, Fernando Magro, et al.
International Immunopharmacology|December 3, 2017
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseasesCaterina Defendenti, Fabiola Atzeni, Sergio Malandrin, et al.
The American Journal of Gastroenterology|January 19, 2005
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD studyVito Annese, Giovanni Lombardi, Francesco Perri, et al.
Fibrogenesis & Tissue Repair|July 10, 2013
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosisPaolo Biancheri, Sylvia Lf Pender, Francesca Ammoscato, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 17, 2010
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel diseaseAmbrogio Orlando, Alessandro Armuzzi, Claudio Papi, et al.
World Journal of Gastroenterology|August 14, 2008
Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in ItalyAnna Latiano, Orazio Palmieri, Maria Rosa Valvano, et al.
Inflammatory Bowel Diseases|February 28, 2014
Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysisNatalie Filmann, Julia Rey, Sven Schneeweiss, et al.
Molecular Biology and Evolution|June 18, 2011
An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseasesManuela Sironi, Franca Rosa Guerini, Cristina Agliardi, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 23, 2021
Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's diseaseGianluca M Sampietro, Giovanni Maconi, Francesco Colombo, et al.
Haematologica|October 10, 2009
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatmentGaetano Bergamaschi, Antonio Di Sabatino, Riccardo Albertini, et al.
Journal of Crohn'S & Colitis|September 24, 2011
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel diseaseLaurent Peyrin-Biroulet, Marc Ferrante, Fernando Magro, et al.
International Immunopharmacology|December 3, 2017
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseasesCaterina Defendenti, Fabiola Atzeni, Sergio Malandrin, et al.
The American Journal of Gastroenterology|January 19, 2005
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD studyVito Annese, Giovanni Lombardi, Francesco Perri, et al.
Fibrogenesis & Tissue Repair|July 10, 2013
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosisPaolo Biancheri, Sylvia Lf Pender, Francesca Ammoscato, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 17, 2010
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel diseaseAmbrogio Orlando, Alessandro Armuzzi, Claudio Papi, et al.
World Journal of Gastroenterology|August 14, 2008
Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in ItalyAnna Latiano, Orazio Palmieri, Maria Rosa Valvano, et al.
Inflammatory Bowel Diseases|February 28, 2014
Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysisNatalie Filmann, Julia Rey, Sven Schneeweiss, et al.
Molecular Biology and Evolution|June 18, 2011
An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseasesManuela Sironi, Franca Rosa Guerini, Cristina Agliardi, et al.
Pageof 16